SCHEMBL14207873

SCHEMBL14207873

C=C(O)[C@]1(C)CCC[C@]2(C)c3ccc(C(C)C)cc3C(=O)C[C@@H]12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.74
▸ MAPT P10636 2/20 0.74
▸ ALOX15 P16050 2/20 0.74
▸ ALDH1A1 P00352 1/20 0.74
▸ AR P10275 2/20 0.59
▸ ESR1 P03372 1/20 0.55
▸ ESR2 Q92731 1/20 0.55
▸ KARS1 Q15046 4/20 0.52
▸ RXRA P19793 1/20 0.52
▸ CCNE1 P24864 1/20 0.52
▸ CDK2 P24941 1/20 0.52
▸ RXRB P28702 1/20 0.52
▸ RXRG P48443 1/20 0.52
▸ LMNA P02545 1/20 0.48
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ PDK1 Q15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14201538 0.91 CYP3A4 (0.74) CYP3A4MAPTALOX15ALDH1A1AR
SCHEMBL3212768 0.90 CYP3A4 (0.78) CYP3A4MAPTALOX15ALDH1A1AR
SCHEMBL20364223 0.90 CYP3A4 (0.78) CYP3A4MAPTALOX15ALDH1A1AR
7-Oxocallitrisic Acid, Methyl Ester SCHEMBL15339316 0.85 CYP3A4 (1.00) CYP3A4MAPTALOX15ALDH1A1AR
SCHEMBL3706021 0.83 CYP3A4 (0.69) CYP3A4MAPTALOX15ALDH1A1AR
SCHEMBL15344775 0.83 CYP3A4 (0.81) CYP3A4MAPTALOX15ALDH1A1AR
SCHEMBL31291111 0.81 AR (0.68) CYP3A4MAPTALOX15ALDH1A1AR
SCHEMBL15388987 0.80 CYP3A4 (0.64) CYP3A4MAPTALOX15ALDH1A1AR
SCHEMBL15388986 0.80 CYP3A4 (0.64) CYP3A4MAPTALOX15ALDH1A1AR
SCHEMBL19283113 0.79 CYP3A4 (0.74) CYP3A4MAPTALOX15ALDH1A1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008061720-A2 USE OF TRICYCLIC DITERPENES AND THEIR DERIVATIVES FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS AND/OR JOINT DISORDERS DSM IP ASSETS B.V. (NL) 2008-05-29 — — WO disclosed
Send feedback